Publications by authors named "Peter Mudry"

Claim this Profile
C
Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin.
Jana Pokludová, Petr Lapčík, Iva Staniczková Zambo, Jiří Kohoutek, Danica Zapletalová

Cancer Cell Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma. How much is enough?".
Henry C Mandeville, Gianni Bisogno, Veronique Minard-Colin, Rita Alaggio, Myriam Ben-Arush, Peter Mudry

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteosarcomas of the hand and foot: A sarcoma‑center case series experience.
Michal Mahdal, Vasileios Apostolopoulos, Lukáš Pazourek, Iva Staniczková Zambo, Dagmar Adámková

Oncol Lett· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial.
Henry C Mandeville, Gianni Bisogno, Veronique Minard-Colin, Rita Alaggio, Myriam Ben-Arush, Peter Mudry

Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Performance of Integrative Clinical Genomics in Pediatric Precision Oncology.
Petra Pokorna, Hana Palova, Sona Adamcova, Robin Jugas, Dagmar Al Tukmachi, Peter Mudry

Lab Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.
Lucie Curylova, Iva Staniczkova Zambo, Jakub Neradil, Michal Kyr, Nicola Jurackova, Peter Mudry

Cell Oncol (Dordr)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients.
Michal Kyr, Peter Mudry, Kristyna Polaskova, Lenka Zdrazilova Dubska, Regina Demlova

Int J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.
Hana Palova, Anirban Das, Petra Pokorna, Viera Bajciova, Zdenek Pavelka, Peter Mudry

NPJ Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for tumors or leukemia development in the first two years of life.
Hana Wiedermannova, Peter Mudry, Jan Pavlicek, Hana Tomaskova, Andrea Hladikova

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone.
Michal Mahdal, Tomáš Tomáš, Vasileios Apostolopoulos, Dagmar Adámková, Peter Múdry

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.
Martin Sterba, Petra Pokorna, Renata Faberova, Blanka Pinkova, Jarmila Skotakova, Peter Mudry

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study.
Gianni Bisogno, Veronique Minard-Colin, Ilaria Zanetti, Andrea Ferrari, Soledad Gallego, Peter Mudry

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.
Petra Pokorna, Giannoula Lakka Klement, Alzbeta Vasikova, Veronika Kanderova, Marta Jezova, Peter Mudry

JCO Precis Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.
Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo, Ladislava Vymětalová, Martin Šrámek

Clin Exp Metastasis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group.
Gianni Bisogno, Veronique Minard-Colin, Myriam Ben Arush, Julia Daragjati, Beatrice Coppadoro, Peter Mudry

Pediatr Blood Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling.
Michal Mahdal, Jakub Neradil, Peter Mudry, Silvia Paukovcekova, Iva Staniczkova Zambo

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.
Peter Múdry, Michal Kýr, Ondřej Rohleder, Michal Mahdal, Iva Staniczková Zambo

J Bone Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood cancer epidemiology in the Czech Republic (1994-2016).
Denisa Krejci, Michaela Zapletalova, Ivana Svobodova, Viera Bajciova, Peter Mudry

Cancer Epidemiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside.
Kristyna Polaskova, Tomas Merta, Alexandra Martincekova, Danica Zapletalova, Michal Kyr, Peter Mudry

Front Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
Hana Noskova, Michal Kyr, Karol Pal, Tomas Merta, Peter Mudry

Cancers (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, Soledad Gallego Melcón, Johannes H Merks, Peter Mudry

Lancet Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma.
Lenka Fedorova, Peter Mudry, Katerina Pilatova, Iveta Selingerova, Jana Merhautova

Front Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome.
Eva Hlavackova, Katerina Pilatova, Dasa Cerna, Iveta Selingerova, Peter Mudry

Front Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a Mutation Associated with Infantile Myofibromatosis.
Martin Sramek, Jakub Neradil, Petra Macigova, Peter Mudry, Kristyna Polaskova

Int J Mol Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Soledad Gallego, Ilaria Zanetti, Daniel Orbach, Dominique Ranchère, Janet Shipley, Peter Mudry

Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis